Everaars, Henk http://orcid.org/0000-0002-4521-0664
Robbers, Lourens F. H. J.
Götte, Marco
Croisille, Pierre
Hirsch, Alexander
Teunissen, Paul F. A.
van de Ven, Peter M.
van Royen, Niels
Zijlstra, Felix
Piek, Jan J.
van Rossum, Albert C.
Nijveldt, Robin
Funding for this research was provided by:
VU University Medical Center
Article History
Received: 9 February 2018
Revised: 9 April 2018
Accepted: 17 April 2018
First Online: 8 June 2018
Compliance with ethical standards
:
: The scientific guarantor of this publication is Robin Nijveldt, MD PhD.
: Dr. van Royen received unrestricted research grants from Volcano Corp. The other authors report no conflicts of interest.
: Peter van de Ven kindly provided statistical advice for this manuscript and performed advanced statistical analysis.
: Written informed consent was obtained from all patients in this study.
: Both trials were approved by the Institutional review board of the VU University Medical Center.
: This study is a pooled analysis of data from patients enrolled in the HEBE trial and the PREDIC-MVO trial. The main results of these trials have been published before (Teunissen et al. Circ Cardiovasc Interv 2015 and Hirsch et al. European Heart Journal 2011).
: • prospective• observational• performed at one institution